Cargando…

Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution

BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugita, Hiroki, Okabe, Hirohisa, Ogawa, Daisuke, Hirao, Hiroki, Kuroda, Daisuke, Taki, Katsunobu, Tomiyasu, Shinjiro, Hirota, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617438/
https://www.ncbi.nlm.nih.gov/pubmed/36307795
http://dx.doi.org/10.1186/s12893-022-01825-3
_version_ 1784820839832616960
author Sugita, Hiroki
Okabe, Hirohisa
Ogawa, Daisuke
Hirao, Hiroki
Kuroda, Daisuke
Taki, Katsunobu
Tomiyasu, Shinjiro
Hirota, Masahiko
author_facet Sugita, Hiroki
Okabe, Hirohisa
Ogawa, Daisuke
Hirao, Hiroki
Kuroda, Daisuke
Taki, Katsunobu
Tomiyasu, Shinjiro
Hirota, Masahiko
author_sort Sugita, Hiroki
collection PubMed
description BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum CA19-9 levels were associated with POPF in PDAC patients. METHODS: This cohort study was conducted at a single institution retrospectively. Clinicopathologic features were determined using medical records. RESULTS: Among of 196 consecutive patients who underwent pancreatectomy against PDAC, 180 patients whose CA19-9 levels were above the measurement sensitivity, were registered in this study. The patients consisted of 122 patients who underwent pancreaticoduodenectomy and 58 patients who underwent distal pancreatectomy. Several clinicopathological factors, including CA 19-9 level, as well as surgical factors were determined retrospectively based on the medical records. Patients with high CA19-9 levels had a significantly higher incidence of POPF than those with low levels (43.9 vs. 13.0%, P < 0.0001). The receiver operating characteristic curves calculated that the cutoff CA19-9 value to predict POPF was 428 U/mL. CA19-9, BMI, curability, and histology were statistically significant risk factors for POPF by univariate analysis. Multivariate analysis showed that CA19-9 and BMI levels were statistically significant independent risk factors for POPF. CA19-9 levels were correlated with both histology and curability. Disease free survival and overall survival of patients with higher levels of CA19-9 were significantly shorter than that of patients with lower levels of preoperative serum CA19-9. CONCLUSIONS: In patients undergoing pancreatectomy for PDAC, higher preoperative CA19-9 levels are a significant predictor for POPF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01825-3.
format Online
Article
Text
id pubmed-9617438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96174382022-10-30 Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution Sugita, Hiroki Okabe, Hirohisa Ogawa, Daisuke Hirao, Hiroki Kuroda, Daisuke Taki, Katsunobu Tomiyasu, Shinjiro Hirota, Masahiko BMC Surg Research BACKGROUND: Postoperative pancreatic fistula (POPF) is a critical complication of pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC). Recent papers reported that serum carbohydrate antigen (CA)19-9 levels predicted long-term prognosis. We investigated whether preoperative serum CA19-9 levels were associated with POPF in PDAC patients. METHODS: This cohort study was conducted at a single institution retrospectively. Clinicopathologic features were determined using medical records. RESULTS: Among of 196 consecutive patients who underwent pancreatectomy against PDAC, 180 patients whose CA19-9 levels were above the measurement sensitivity, were registered in this study. The patients consisted of 122 patients who underwent pancreaticoduodenectomy and 58 patients who underwent distal pancreatectomy. Several clinicopathological factors, including CA 19-9 level, as well as surgical factors were determined retrospectively based on the medical records. Patients with high CA19-9 levels had a significantly higher incidence of POPF than those with low levels (43.9 vs. 13.0%, P < 0.0001). The receiver operating characteristic curves calculated that the cutoff CA19-9 value to predict POPF was 428 U/mL. CA19-9, BMI, curability, and histology were statistically significant risk factors for POPF by univariate analysis. Multivariate analysis showed that CA19-9 and BMI levels were statistically significant independent risk factors for POPF. CA19-9 levels were correlated with both histology and curability. Disease free survival and overall survival of patients with higher levels of CA19-9 were significantly shorter than that of patients with lower levels of preoperative serum CA19-9. CONCLUSIONS: In patients undergoing pancreatectomy for PDAC, higher preoperative CA19-9 levels are a significant predictor for POPF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01825-3. BioMed Central 2022-10-28 /pmc/articles/PMC9617438/ /pubmed/36307795 http://dx.doi.org/10.1186/s12893-022-01825-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sugita, Hiroki
Okabe, Hirohisa
Ogawa, Daisuke
Hirao, Hiroki
Kuroda, Daisuke
Taki, Katsunobu
Tomiyasu, Shinjiro
Hirota, Masahiko
Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title_full Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title_fullStr Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title_full_unstemmed Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title_short Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
title_sort preoperative serum ca19-9 predicts postoperative pancreatic fistula in pdac patients: retrospective analysis at a single institution
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617438/
https://www.ncbi.nlm.nih.gov/pubmed/36307795
http://dx.doi.org/10.1186/s12893-022-01825-3
work_keys_str_mv AT sugitahiroki preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT okabehirohisa preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT ogawadaisuke preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT hiraohiroki preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT kurodadaisuke preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT takikatsunobu preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT tomiyasushinjiro preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution
AT hirotamasahiko preoperativeserumca199predictspostoperativepancreaticfistulainpdacpatientsretrospectiveanalysisatasingleinstitution